You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

PRAVACHOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pravachol patents expire, and when can generic versions of Pravachol launch?

Pravachol is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in PRAVACHOL is pravastatin sodium. There are sixteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pravachol

A generic version of PRAVACHOL was approved as pravastatin sodium by TEVA on April 24th, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PRAVACHOL?
  • What are the global sales for PRAVACHOL?
  • What is Average Wholesale Price for PRAVACHOL?
Drug patent expirations by year for PRAVACHOL
Drug Prices for PRAVACHOL

See drug prices for PRAVACHOL

Drug Sales Revenue Trends for PRAVACHOL

See drug sales revenues for PRAVACHOL

Recent Clinical Trials for PRAVACHOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AmgenPhase 4
Brigham and Women's HospitalPhase 4
Mayo ClinicPhase 2

See all PRAVACHOL clinical trials

Paragraph IV (Patent) Challenges for PRAVACHOL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PRAVACHOL Tablets pravastatin sodium 30 mg 019898 1 2005-06-01

US Patents and Regulatory Information for PRAVACHOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-002 Oct 31, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-008 Dec 18, 2001 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-003 Oct 31, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb PRAVACHOL pravastatin sodium TABLET;ORAL 019898-004 Mar 22, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PRAVACHOL

International Patents for PRAVACHOL

See the table below for patents covering PRAVACHOL around the world.

Country Patent Number Title Estimated Expiration
Denmark 155689 ⤷  Sign Up
Canada 2172884 ⤷  Sign Up
Japan S572240 ML-236B DERIVATIVE ⤷  Sign Up
United Kingdom 2077264 ML-236B DERIVATIVES AND THEIR PREPARATION ⤷  Sign Up
Australia 5074196 ⤷  Sign Up
Australia 624117 ⤷  Sign Up
European Patent Office 0461548 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.